Identifying Neuroimaging Biomarkers of Resilience and Vulnerability to Chronic Stress in An Animal Model: An Exploratory Analysis
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Stress is a main contributor to mood disorders, with individuals displaying great heterogeneity in response to stressful life events and adversity. Identifying biomarkers of vulnerability and resilience to stress would facilitate a prevention-based approach to mental illness that benefits individuals and reduces healthcare costs. The present study adopted a multivariate machine-learning approach to track neuroimaging biomarkers predictive of resilience and vulnerability following a chronic restraint stress (CRS) model. 96 male Sprague-Dawley rats underwent two sessions of MRI and behavioral tests, before and after CRS. Resilience and vulnerability to CRS were assessed with elevated plus maze and forced swimming tests. Hierarchical clustering was applied to construct brain networks. Partial correlation was used to compute network connectivity. Repeated nested cross validation with a support vector machine was employed to identify rs-fMRI biomarkers predictive of resilience and vulnerability following CRS. No strong group effect size of behavioral changes following CRS was observed within the same animals, suggesting the presence of resilient and vulnerable subgroups. Although the average model performance was modest (area under the receiver operating characteristic curve: 0.3 ∼ 0.67), baseline functional connectivity across cerebellum, brainstem, striatum, prefrontal and salience-orbitofrontal regions, as well as functional alteration across hippocampus, striatum, prefrontal regions, auditory thalamus, cerebellum, inferior colliculi and brainstem were identified as stable features. The present study is the first to identify connectome-based neuroimaging biomarkers predictive of resilience and vulnerability using an animal model. The results may provide insights into neuroimaging biomarkers to aid diagnosis and prevention of mood disorders in humans.